Issue 32, 2025, Issue in Progress

Label-free biosensing of microRNA-423-5p in saliva sample of patients using KAUST catalysis center-1 modified dendritic AuNPs: a new platform towards early-stage diagnosis of oral cancer

Abstract

Oral squamous cell carcinoma (OSCC) is the most prevalent form of oral cavity cancer and a leading cause of death globally with low survival rates. Early detection of OSCC is crucial for reducing morbidity and mortality. The microRNA-423-5p, a 23-nucleotide non-coding RNA, is a vital biomarker for accurate OC detection due to its high value in the Receiver Operating Characteristic (ROC) curve, ensuring selectivity for OC. A precise measurement of microRNA-423-5p in human biofluids facilitates accurate OC detection. This research introduces a novel electrochemical platform without the need for labeling, designed for the non-intrusive monitoring of microRNA-423-5p in human saliva samples using a DNA-based bioassay. In this approach, poly(β-cyclodextrin) was fabricated to serve as a biocompatible support on the glassy carbon electrode surface. Furthermore, KCC-1-nPr-NH-Arg, featuring a surface area of 104.9 m2 g−1 and a pore volume of 0.83 cm3 g−1, was utilized to enhance the substrate's surface area relative to volume and achieve high loading of probe DNA (pDNA). For the first time, dendritic AuNPs were used to immobilize thiolated DNA sequences (5′-SH-TGTCTCCCCGGTGTCTGGCTCGA-3′) on an electrode surface of electrode via Au–S interaction to detect microRNA-423-5p in human saliva in low limit of quantification of 1 pM. The biosensor successfully detected microRNA-423-5p, demonstrating its potential for OC screening. The genosensor development involved assessing crucial factors such as hybridization time and microRNA concentration. Analytical techniques including cyclic voltammetry, chronoamperometry, and differential pulse voltammetry were used for quantifying MicroRNA-423-5p in human biofluids. The biosensor's performance characteristics were evaluated for stability, repeatability, and suitability for plasma and saliva samples.

Graphical abstract: Label-free biosensing of microRNA-423-5p in saliva sample of patients using KAUST catalysis center-1 modified dendritic AuNPs: a new platform towards early-stage diagnosis of oral cancer

Supplementary files

Article information

Article type
Paper
Submitted
25 May 2025
Accepted
15 Jul 2025
First published
22 Jul 2025
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2025,15, 26000-26012

Label-free biosensing of microRNA-423-5p in saliva sample of patients using KAUST catalysis center-1 modified dendritic AuNPs: a new platform towards early-stage diagnosis of oral cancer

H. Bahari, M. Hasanzadeh, S. Davaran, F. Ahmadpour and N. Shadjou, RSC Adv., 2025, 15, 26000 DOI: 10.1039/D5RA03672K

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements